Annals of Family Medicine
NOVEMBER 20, 2024
Objective: To assess the feasibility of implementing a lifestyle medicine program in a rural Ontario community for patients with chronic diseases. Results: Cohort one of eight participants completed CLIP-ON in April 2024. Qualitative feedback is collected through questionnaires and focus groups.
Annals of Family Medicine
NOVEMBER 20, 2024
Study Design and Analysis: This qualitative study conducted semi-structured focus groups among 24 Spanish-preferred Latino farmworkers from January to March 2024. The focus group sessions were audio-recorded and transcribed verbatim. The analysis was conducted entirely in Spanish by bilingual investigators and research assistants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Annals of Family Medicine
NOVEMBER 20, 2024
Motivation to overcome the many challenges is needed to meet the critical need for high quality, lifelong management of OUD, just as with any other chronic disease. Context: Expansion of medication for opioid use disorder (MOUD) within primary care practices is often met with resistance.
Common Sense Family Doctor
FEBRUARY 28, 2025
A 2024 analysis projected that by 2040 a shortage of 58,000 primary care clinicians (including nurse practitioners and physician assistants) will occur. hours per day, with more than one-half of that time (14.1 hours) allocated to preventive care.
The Physicians Foundation
AUGUST 15, 2024
is honored for his transformative work, connecting patients with primary care and critical health resources BOSTON, August 15, 2024 – The Physicians Foundation is proud to announce Jubril Oyeyemi, M.D., In July 2024, The Physicians Foundation also honored E. Jubril Oyeyemi, M.D., Mirna Mohanraj, M.D. ,
FDA Law Blog
JANUARY 12, 2025
Sasinowski On December 5, 2024, FDA published a new draft guidance on accelerated approval providing a much needed and substantial update to its guidance on the pathway. FDAs December 5, 2024 draft guidance on accelerated approvals appears intended to cover each of these topics even if not by dividing them precisely along those lines.
Today's Hospitalist
JUNE 7, 2025
Laudenslager, is a chronic metabolic disease with highly complex pathophysiology—”and we are programmed to regain the weight we lose with lifestyle measures.” Published in May 2024, the FLOW trial , for instance, looked at patients with diabetes and advanced kidney disease.
Expert insights. Personalized for you.
130 
Let's personalize your content